Jacqueline Forget, CamilleRuiz-Carrascoso, GuillermoGutiérrez-Fernández, JoséVicente Rangel, TeresaGoterris, LidiaVázquez-Valdés, FernandoVecilla, Domingo FernándezElía-López, MatildeMartinez Ruiz, Maria RocíoAspiroz Sancho, CarmenPérez-Tanoira, RamónSirvent Quílez, Eliala Rica Martínez, Alba deGonzalo Jiménez, NievesGarcía Salguero, CristinaGonzález-Barberá, EvaSánchez Florez, Maria ReyesMerino, Francisco JSagardia Redondo, BegoñaRodriguez Guerrero, EnriqueSanz González, ClaudiaHerrera-León, Silvia2024-03-182024-03-182023-11Emerg Infect Dis. 2023 Nov;29(11):2370-2373.http://hdl.handle.net/20.500.12105/18970In 2022, the United Kingdom reported an increase in drug resistance in Shigella sonnei isolates. We report 33 cases in Spain genetically related to the UK cases and 4 cases with similar antimicrobial resistance profiles infected with genetically distant strains. Our results suggest circulation of multiple genetic clusters of multidrug-resistant S. sonnei in Spain.engVoRhttp://creativecommons.org/licenses/by/4.0/Dysentery, BacillaryAnti-Infective AgentsShigellaHumansShigella sonneiAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialSpainMicrobial Sensitivity TestsDrug Resistance, BacterialAtribución 4.0 Internacional3787761929112370-237310.3201/eid2911.2217461080-6059Emerging infectious diseasesopen access